1. Home
  2. FBIN vs PCVX Comparison

FBIN vs PCVX Comparison

Compare FBIN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

HOLD

Current Price

$51.18

Market Cap

6.2B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$47.24

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIN
PCVX
Founded
1988
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FBIN
PCVX
Price
$51.18
$47.24
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$65.56
$101.67
AVG Volume (30 Days)
1.5M
1.5M
Earning Date
02-05-2026
11-04-2025
Dividend Yield
2.03%
N/A
EPS Growth
N/A
N/A
EPS
2.67
N/A
Revenue
$4,489,900,000.00
N/A
Revenue This Year
$0.09
N/A
Revenue Next Year
$2.30
N/A
P/E Ratio
$19.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.04
$27.66
52 Week High
$75.82
$93.77

Technical Indicators

Market Signals
Indicator
FBIN
PCVX
Relative Strength Index (RSI) 53.31 55.66
Support Level $49.58 $42.40
Resistance Level $51.49 $48.65
Average True Range (ATR) 1.34 1.61
MACD -0.03 0.22
Stochastic Oscillator 54.19 77.06

Price Performance

Historical Comparison
FBIN
PCVX

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: